ACgro CD Medium for Adherent Cell
video

ACgro CD Medium for Adherent Cell

Serum-Free Culture · Stable for Vaccine Production · High Virus Yield
Traditionally, adherent cells are cultured using culture medium supplemented with 10% serum. However, serum poses challenges such as significant batch-to-batch variability, animal-derived risks, and uncontrolled costs.
ACgro CD Medium is a chemically defined, animal component-free solution that overcomes serum dependency. It supports the growth of various adherent cells, including Vero, 293, and MDCK, providing a safer, more stable, and cost-effective cell culture solution for vaccine development, production, and basic research.
Send Inquiry

Description

Performance

Features

  • product-12-12

    Serum-free, chemically defined, animal-derived component free, ultra-low protein

  • product-12-12

    Supports serum-free culture for Vero, MDCK, DF-1, 293, and other adherent cell lines.

  • product-12-12

    Scalable in cell factories, microcarriers & multilayer flasks

  • product-12-12

    Ideal for the production of various human and veterinary vaccines, including rabies, hand-foot-and-mouth disease (HFMD), herpes zoster, varicella, and more.

Advantages

product-1-1

Safe & Stable
Ensuring reliable vaccine production
Chemically defined formulation Eliminates serum-induced batch variability
Maintains morphology & >90% viability beyond Passage 50

product-1-1

Cost-Effective & Controllable
Eliminates serum price volatility
Reduces QC costs through serum-free testing
Minimizes contamination risks and production losses

product-1-1

Regulatory compliance
GMP-compliance facility with ISO 13485 & MDSAP (FDA) certified
Complete regulatory support documentation

product-1-1

Custom Solutions
Custom-optimized for specific project requirements
30+ years dedicated R&D expertise
Proven in 100+ vaccine development programs
End-to-end technical service support

Order Information

Basal Medium

Product 

Cat. No.

Form

Size

Packaging Note
ACgro CD Medium TP0112901E

Powder

10 L

Bag

  • Serum-free, chemically defined, animal-derived component free, ultra-low protein
  • Add additive to poeder media at 0.75‰ (v/v)
TP0112903E Powder

200L

Bag
ACgro Additive TP0202201

Liquid

50ml

Bottle
TP0202202 Liquid 150ml Bottle

Performance

Vaccines

(1)Optimal morphology
Vero cells cultured in ACgro CD medium exhibited clear, intact boundaries and typical spindle-shaped morphology, comparable to both traditional 10% serum-containing cultures and serum-free media of Brand A and Brand B.

product-942-189

(2)Long-term stable passaging
ACgro CD medium supports consistent long-term subculture of Vero cells for extended passages (≥80 generations) with stable growth characteristics.

product-1694-324

(3)Shorter doubling time
Vero cells cultured in ACgro CD medium exhibited a doubling time of 23 hours - comparable to serum-containing cultures (MEM+10% FBS) and significantly shorter than other commercial serum-free media.

(4)Significantly Enhanced PEDV Yield
PEDV (Porcine Epidemic Diarrhea Virus) titers in ACgro CD medium reached 108.11TCID50/mL - a significant increase over both traditional culture (MEM+10% FBS) and other commercial serum-free media.

(5)Significantly Enhanced PRV Yield
In ACgro CD medium, the pseudorabies virus (PRV) titer reached 108.5 TCID50/mL, comparable to traditional serum-containing culture (DMEM + 2% FBS) and significantly higher than other commercial serum-free media.

FAQ

Q1:Why are Vero cells good for growing viruses?

Q2:Why are Vero cells used for vaccines?

Q3:What is the DMEM for Vero cells?

Hot Tags: ACgro CD Medium for Adherent Cell, China ACgro CD Medium for Adherent Cell manufacturers, suppliers, factory

product-16-16 Antibodies

In fed-batch process, CHO cells cultured in Eden CD CHO media demonstrate higher viable cell density (VCD) and protein production than competitors. On average, the antibody titers of various CHO cell lines cultured in Eden CD CHO media ranged from 2 to 11 g/L.

 

product-1200-694

 

In the pulse perfusion process, CHO cells cultured in Eden CD CHO media demonstrated superior performance than competitive global brands. When VVD=1.0, volumetric productivity (Vp) can reach up to 2.2 g/L/day, and the cumulative product expression in 14 days can reach 19 g/L, 55% higher than global brand B. When VVD=2.0, Vp can reach up to 3.3g/L/day, and the cumulative product expression in 14 days can reach 25 g/L.

 

product-1200-576

 

Brochures
CHO Cell Medium

product-40-40

FAQ

Q1: What is the packaging for BioEngine's powder media?

A:All of our powder media products are packaged in aluminum foil bags. The aluminum foil bags provide excellent light protection, low water permeability, and low oxygen permeability, effectively preventing the deterioration of powdered culture media due to light exposure, humidity, and oxidation. You can view product images on the respective product pages.

Q2: Can we seal the bag if there is leftover powdered medium?

A: This product is highly hygroscopic. It is recommended to use it immediately after opening. If further storage is necessary, strict sealing methods such as heat sealing or using sealing clips should be employed to seal tightly and prevent moisture absorption that may lead to product failure.

Q3: What is the shelf life of BioEngine's Eden series CHO cell culture media, and how do you verify the expiration date?

A: The Eden series CHO culture media have a shelf life of 1 to 2 years, validated through real-time stability experiments and accelerated testing.

Q4: Does BioEngine offer any regulators or additives for modulating antibody glycosylation?

A: Currently, there are no quality-adjusting agent products available. However, we can provide some experimental protocols based on customer data to assist them in antibody/protein quality modulation.

Q5: Does BioEngine's CHO cell culture media contain hydrolysates, insulin, cytokines, or other components?

A: The Eden series CHO culture media do not contain hydrolysates, insulin, cytokines, glutamine, antibiotics, HEPES, phenol red, and HT (Hypoxanthine and Thymidine). If your cell line is dependent on cytokines, hydrolysates, glutamine, or nucleotides (such as hypoxanthine and thymidine), it is recommended to add appropriate concentrations of these substances to the Eden series culture media.

Q6: What are CHO media?

A: CHO media refers to cell culture media specifically designed for the growth and maintenance of Chinese hamster ovary (CHO) cells, which are commonly used in biotechnology and pharmaceutical industries to produce therapeutic proteins and monoclonal antibodies. CHO media are typically composed of a variety of nutrients, growth factors, and supplements that promote cell growth, proliferation, and protein expression in these cells. There are several types of CHO media available with different formulations optimized for specific applications, including serum-free and chemically defined options. The Eden series CHO culture media provided by BioEngine are chemically defined media that are serum-free, protein-free, and animal-derived components free.

Q7: What are the differences between DMEM and RPMI?

A:DMEM and RPMI are two commonly used types of media for cell culture, and they have some differences in their composition and usage. Here are some of the key differences:

 

1. Nutrient composition: DMEM (Dulbecco's Modified Eagle's Medium) and RPMI (Roswell Park Memorial Institute) have different nutrient compositions. DMEM contains higher levels of glucose, amino acids, vitamins, and sodium pyruvate, while RPMI has a lower glucose concentration and a different amino acid and vitamin composition.

2. pH: DMEM has a higher pH (7.4-7.6) compared to RPMI (7.2-7.4).

3. Usage: DMEM is a more general-purpose medium and can be used for a wide range of cell types, including adherent and non-adherent cells, while RPMI is typically used for the culture of immune cells such as lymphocytes and hybridomas.

4. Serum requirement: RPMI is often used with lower serum concentrations (e.g. 5-10%) than DMEM, which may require higher serum concentrations (e.g. 10-20%).

Overall, the choice between DMEM and RPMI depends on the specific cell type being cultured and the experimental conditions.

Q8: What is a fed-batch culture?

A:Fed-batch culture is a type of bioreactor operation used in industrial biotechnology to cultivate microorganisms or cells for the production of various bioproducts, such as vaccines, enzymes, and biofuels. In a fed-batch culture, a small initial volume of culture medium is used to inoculate a bioreactor, which is then gradually supplemented with additional nutrients, such as sugars, amino acids, and vitamins, over the course of the culture process.

 

The goal of a fed-batch culture is to maximize cell growth and productivity while maintaining a stable culture environment. By controlling the rate and timing of nutrient addition, the culture can be kept in a state of controlled growth, avoiding the depletion of nutrients and accumulation of waste products that can limit growth and product formation in batch cultures. Additionally, the use of a fed-batch culture can allow for the accumulation of high cell densities and the optimization of production conditions, leading to higher yields and greater efficiency in bioprocesses.

Q9: What are the advantages of suspension cell cultures?

A:Suspension cell culture is a type of cell culture where cells are grown in a liquid medium and are suspended in the culture medium, as opposed to being attached to a surface or substrate. Some of the advantages of suspension cell culture are:

 

1. Scalability: Suspension cell cultures can be easily scaled up to produce large quantities of cells. This makes them particularly useful for biomanufacturing and the production of recombinant proteins.

2. Flexibility: Suspension cultures can be adapted to a wide range of culture conditions, such as pH, temperature, and nutrient availability. This allows for the optimization of cell growth and productivity.

3. Homogeneity: Suspension cultures provide a more homogeneous population of cells than adherent cultures, where cells may exhibit varying degrees of differentiation and proliferation.

4. Reduced risk of contamination: Suspension cultures are less prone to contamination by bacteria or fungi than adherent cultures, as there are no surfaces for microorganisms to adhere to.

5. Ease of harvesting: Cells in suspension culture can be easily harvested using centrifugation, filtration, or other methods. This simplifies downstream processing and reduces the risk of damage to the cells.

 

Overall, suspension cell culture offers several advantages over other types of cell culture, particularly in the context of large-scale biomanufacturing and the production of recombinant proteins.

Q10: What is gene therapy?

A:"Gene therapy is a technique that modifies a person's genes to treat or cure disease 1. Gene therapy can work by several mechanisms, such as:

●Replacing a disease-causing gene with a healthy copy of the gene.

●Inactivating or deleting a disease-causing gene.

●Introducing a new or modified gene to help fight disease.

 

Gene therapy is a promising and innovative field of medicine that has potential applications for many diseases, such as cancer, genetic disorders, infectious diseases, and autoimmune diseases 23. However, gene therapy also faces many challenges and risks, such as safety, efficacy, ethical issues, and regulatory hurdles.

Gene therapy usually be delivered to the cells by virus vector, such as AAV, Adv and RV. BioEngine provides vigor series insect cell media for large scale AAV production."

Q11: Does BioEngine provides serum products, like FBS?

A: NO. BioEngine provides various serum-free media products and cell culture services.
[[ProInfoAttach]]
[[ProDetailSubTitle2]]

Send Inquiry

Provide high quality culture media for research institutions, biopharmaceutical companies and clinical trial institutions, etc.

I agree to receive other communications from BioEngine which may contain technical or marketing information from this organization. You can unsubscribe from these communications at any time.
By submitting this form, you are agreeing to the terms and conditions of our Privacy Policy

Professional Cell Culture Solutions for Biopharmaceutical Development

Our expert scientific team delivers end-to-end cell culture services to support your biopharmaceutical production needs. We provide comprehensive solutions including:
- Process development & optimization
- Customized medium formulation design
- Scalable medium processing & GMP manufacturing

For technical inquiries or service requests, please submit your message through our [Quick Message] portal. Our specialists will respond within 24 business hours.

For urgent matters, please contact +86 137 5514 6322 directly